title: Dramatic improvement of subcutaneous insulin resistance with nafamostat ointment treatment.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Kawashima
authors.forename: Hideaki
authors.initials: H
authors.lastname: Kaneto
authors.forename: Ken'ya
authors.initials: K
authors.lastname: Sakamoto
authors.forename: Ikuko
authors.initials: I
authors.lastname: Honsho
authors.forename: Tetsuyuki
authors.initials: T
authors.lastname: Yasuda
authors.forename: Akio
authors.initials: A
authors.lastname: Kuroda
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Shiraiwa
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Kasami
authors.forename: Taka-aki
authors.initials: TA
authors.lastname: Matsuoka
authors.forename: Yoshimitsu
authors.initials: Y
authors.lastname: Yamasaki
authors.forename: Munehide
authors.initials: M
authors.lastname: Matsuhisa
mesh_terms: D001550:Benzamidines; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy; D005260:Female; D006146:Guanidines / Q000008:administration & dosage*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D007333:Insulin Resistance; D008875:Middle Aged; D009824:Ointments; D016896:Treatment Outcome
chemical_list: D001550:Benzamidines; D006146:Guanidines; D007004:Hypoglycemic Agents; D007328:Insulin; D009824:Ointments; C032855:nafamostat